Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II

Thrombosis Research

Volumn 84, Issue 1, 1996, Pages 21-32

  Mascellani, Giuseppe ^a   Liverani, Lino ^a   Parma, Bruna ^a   Bergonzini, GianLuca ^a   Bianchini, Pietro ^a  

^a Opocrin SpA Res and Devmt Labs   (Italy)

Author keywords

disulfated disaccharides; heparin cofactor II; inhibition of thrombin; low molecular mass dermatan sulfate; oversulfated sequences

Indexed keywords

DERMATAN SULFATE; DESMIN; HEPARIN COFACTOR II;

ANTICOAGULATION; ARTICLE; PRIORITY JOURNAL;

EID: 0030271870     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00158-2     Document Type: Article

References (23)

1. 1. BIANCHINI, P., BERGONZINI, G.L., LIVERANI, L., MASCELLANI, G., PARMA, B. and PRETE, A. Anticoagulant and antithrombotic properties of dermatan sulphate. Some related structural characteristics thereof.In:Dermatan sulphate Proteoglycans: chemistry, Biology, Chemical Pathology. J.E. Scott (ed.), pp 249-258, Portland Press Ltd, London (1993).
2. 2. DESNOYERS, P., BARA, L., SAMAMA, M. Dermatan sulfate and experimental venous thrombosis prevention. Path. Biol. 37,759,1989.
3. 3. TOLLEFSEN, D.M. Heparin Cofactor II. In : Heparin Chemical and Biological properties, Clinical Applications Lane D.A. and Lindhal U.(ed.) pp 229-255. Edwards Arnold London (1989).
4. 4. MAIMONE, M.M., TOLLEFSEN, D.M. Structure of a Dermatan Sulfate hexasaccharide that Binds to Heparin Cofactor II with high Affinity. J. Biol. Chem. 265(30), 18263-18271, 1990.
5. 5. MASCELLANI, G., LIVERANI, L., BIANCHINI, P., PARMA, B., TORRI, G., BISIO, A, GUERRINI, M. and CASU, B. Structure and contribution to the HCII-mediated inhibition of thrombin of naturally oversulphaled sequences of dermatan sulphate. Biochem. J. 296, 639-648, 1993.
6. 6. MASCELLANI, G., LIVERANI, L., PRETE, A., BERGONZINI, G.L., BIANCHINI, P., SILVESTRO, L., TORRI, G., BISIO, A., GUERRINI, M. and CASU, B. Active sites of Dermatan Sulfate for HCII. Isolation of a nonasaccharide fragment containing four disaccharide sequences [α-L-iduronic acid 2-0-sulfate (1,3)-β-D-N-acetylgalactosamine 4-sulfate). J. Carbohydr. Chem. 14,1165-1177, 1995.
7. 7. MASCELLANI, G., LIVERANI, L., PRETE, A., GUPPOLA, P.A., BERGONZINI, G.L. and BIANCHINI, P. Relative influence of different disulphate disaccharide clusters on the HCII-mediated inhibition of thrombin by dermatan sulphates of different origins. Thromb. Res.74(6),605-615,1994.
8. 8. SIE, P., OFOSU, F., FERNANDEZ, F. et al. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphate polysaccharides. Br.J. Haem. 64, 707, 1986.
9. 9. MASCELLANI, G., BIANCHINI, P. : EP 221.977, B1(1990), US. Patent 4,973,580 (Chem. Abstracts 107, 78204S).
10. 10. VOLPI, N., MASCELLANI, G., BIANCHINI, P. and LIVERANI, L. Analytical techniques for studying structures of DS and LMW DS, II Farmaco 47,(5S),841-853,1992.
11. 11. TAMAGNONE, G.F., BARBANTI, M. Desmin-370. Drugs of the Future. 19(7),638-640,1994.
12. 12. BARBANTI, M., CALANNI, F., BABBINI, M., BERGONZINI, G.L., PARMA, B., MARCHI, E. Antithrombotic activity of Desmin 370. Comparison with a high molecular weight Dermatan sulphate. Thromb. Res. 71,417-422, 1993.
13. 13. BARBANTI, M., CALANNI, F., MILANI, M.R., MARCHI, E., SEMERARO, N., COLUCCI, M. Therapeutic effect of a Low Molecular Weight Dermatan Sulphate (Desmin 370) in rat venous thrombosis. Evidence for an anticoagulant-independent mechanism. Thromb. Haemostas. 69(2),147-151,1993.
14. 14. DETTORI, A.G., MILANI, M.R., MANOTTI, C., ZAMBONI, V., PALAZZINI, E., BARBANTI, M. Pharmacology of Desmin (Low Molecular Weight Dermatan Sulphate) in healthy volunteers following intravenous bolus administration of different dosages (200,400,800 mg). Thromb. Res. 79,249-260,1995.
15. 15. BARTOLUCCI, C., CELLAI, L., IANNELLI, M.A., LAMBA, D., LIVERANI, L., MASCELLANI, G. and PEROLA, E. Inhibition of human leukocyte elastase by chemically and naturally oversulfated galactosaminoglycans. Carbohydr. Res. 276,401-408,1995.
16. 16. ABILGAARD, U. and LARSEN, M. Assay of Dermatan Sulfate Cofactor (Heparin Cofactor II) activity in human plasma. Thromb. Res. 35, 257-266, 1984.
17. 17. NETER, J., WASSERMANN, W., KUNTER, M.H. Applied linear regression model pp.333-374, Irwin, Homewood,IL(1989).
18. 18. LINHARDT, R.J., DESAI, U.R., LIU, J., PERVIN, A., HOPPENSTEADT, D. and FAREED, J. Low molecular weight dermatan sulfate as an antithrombotic agent. Structure-activity relationship. Biochem. Pharmacol. 47,1241-1252,1994.
19. 19. PAVÃO, M.S.G., MOURÃO, P.A.S., MULLOY, B., TOLLEFSEN, M.D. A unique Dermatan Sulfate-like Glycosaminoglycan from Ascidian. J. Biol. Chem. 270(52), 31027-31036,1995.
20. 20. FERRARI, G., MARCHESINI, D. and MAGGI, A.P. : Preliminary chemical, biochemical and pharmacological characterization of a Low Molecular weight dermatan sulphate. Carbohydr. Res. 255,125-132,1994.
21. 21. THOMAS, D.P., GRAY, E. and MERTON, R.E. Potentiation of the antithrombotic action of Dermatan sulphate by small amounts of Heparin. Thromb. Haemost. 64,290-293,1990.
22. 22. COSMI, B., AGNELLI, G., YOUNG, E., HIRSH, J., and WEITZ, J. The additive effect of Low Molecular Weight heparins on thrombin inhibition by Dermatan Sulfate. Thromb. Haemost. 70,443-447,1993.
23. 23. DOL, F., CARANOBE, C., DUPOUY, D., PETITOU, M., LORMEAU, J.C., CHOAY, J., SIÉ, P., BONEAU, B. Effects of increased sulfation of Dermatan sulfate on its in vitro and in vivo pharmacological properties. Thromb. Res. 52,153-164,1988.